Literature DB >> 3539796

Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans.

S A Smith, P J Mace, W A Littler.   

Abstract

The influence of acute and chronic treatment with felodipine on ambulatory intra-arterial blood pressure, certain cardiac reflexes, and plasma renin activity was studied in nine patients with essential hypertension. Acute oral administration of the drug caused a significant reduction in blood pressure associated with an increase in heart rate mediated by the sinoaortic baroreceptor-heart rate reflex. After 1 week of treatment reflex resetting had occurred, returning heart rate to normal despite continuing blood pressure reduction. This effect was maintained throughout 6 weeks of treatment. Withdrawal of treatment was followed by return of the blood pressure to control levels associated with significant bradycardia caused by reflex reactivation at its reset level. No change was observed in response to tilting or Valsalva's maneuver or in plasma renin activity. Ambulatory intra-arterial data suggested that the clinically useful antihypertensive action of felodipine persists for 9 hours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3539796     DOI: 10.1161/01.hyp.8.12.1172

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension.

Authors:  C Porcellati; P Verdecchia; C Gatteschi; G Benemio; M Guerrieri; F Boldrini; G Pollavini
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Felodipine monotherapy in hypertension.

Authors:  W A Littler; S A Smith; P J Mace
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Baroreflex control of renin release in spontaneously hypertensive rats after administration of felodipine.

Authors:  M Nordlander; R Horton; P Thalén
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Felodipine versus hydrochlorothiazide as an addition to a beta-blocker in the treatment of hypertension.

Authors:  H Borgmästars; B Forsén; J Tuomilehto; R Hellebø; P O Walle; H M Nielsen; E Nielsen; O Winkel; E Steiness; H Ibsen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

6.  The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.

Authors:  B Hasselgren; B Edgar; G Johnsson; O Rönn
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Felodipine clinical pharmacokinetics.

Authors:  P H Dunselman; B Edgar
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

8.  The efficacy and tolerability of long-term felodipine treatment in hypertension. The Scandinavian Multicenter Group.

Authors:  H Ibsen; B Westberg
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

9.  Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine.

Authors:  B G Hardy; W R Bartle; M Myers; D G Bailey; B Edgar
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

10.  The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.

Authors:  A D Bainbridge; R J Macfadyen; S Stark; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.